Complement component 5: Difference between revisions

Revision as of 12:36, 29 August 2008

Revision as of 20:55, 15 May 2009

Line 13:

{{PBB_Further_reading

| citations =

*{{cite journal | author=Tack BF, Morris SC, Prahl JW |title=Fifth component of human complement: purification from plasma and polypeptide chain structure. |journal=Biochemistry |volume=18 |issue= 8 |pages= 1490–7 |year= 1979 |pmid= 106884 |doi=10.1021/bi00575a016 }}

*{{cite journal | author=Fernandez HN, Hugli TE |title=Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a. |journal=J. Biol. Chem. |volume=253 |issue= 19 |pages= 6955–64 |year= 1978 |pmid= 690134 |doi= }}

*{{cite journal | author=DiScipio RG |title=Formation and structure of the C5b-7 complex of the lytic pathway of complement. |journal=J. Biol. Chem. |volume=267 |issue= 24 |pages= 17087–94 |year= 1992 |pmid= 1387399 |doi= }}

Line 19:

*{{cite journal | author=Bohnsack JF, Mollison KW, Buko AM, ''et al.'' |title=Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus. |journal=Biochem. J. |volume=273 ( Pt 3) |issue= |pages= 635–40 |year= 1991 |pmid= 1996961 |doi= }}

*{{cite journal | author=Lundwall AB, Wetsel RA, Kristensen T, ''et al.'' |title=Isolation and sequence analysis of a cDNA clone encoding the fifth complement component. |journal=J. Biol. Chem. |volume=260 |issue= 4 |pages= 2108–12 |year= 1985 |pmid= 2579066 |doi= }}

*{{cite journal | author=Zuiderweg ER, Fesik SW |title=Heteronuclear three-dimensional NMR spectroscopy of the inflammatory protein C5a. |journal=Biochemistry |volume=28 |issue= 6 |pages= 2387–91 |year= 1989 |pmid= 2730871 |doi=10.1021/bi00432a008 }}

*{{cite journal | author=Zuiderweg ER, Nettesheim DG, Mollison KW, Carter GW |title=Tertiary structure of human complement component C5a in solution from nuclear magnetic resonance data. |journal=Biochemistry |volume=28 |issue= 1 |pages= 172–85 |year= 1989 |pmid= 2784981 |doi=10.1021/bi00427a025 }}

*{{cite journal | author=Haefliger JA, Tschopp J, Vial N, Jenne DE |title=Complete primary structure and functional characterization of the sixth component of the human complement system. Identification of the C5b-binding ___domain in complement C6. |journal=J. Biol. Chem. |volume=264 |issue= 30 |pages= 18041–51 |year= 1989 |pmid= 2808363 |doi= }}

*{{cite journal | author=Wetsel RA, Lemons RS, Le Beau MM, ''et al.'' |title=Molecular analysis of human complement component C5: localization of the structural gene to chromosome 9. |journal=Biochemistry |volume=27 |issue= 5 |pages= 1474–82 |year= 1988 |pmid= 3365401 |doi=10.1021/bi00405a012 }}

*{{cite journal | author=Zuiderweg ER, Mollison KW, Henkin J, Carter GW |title=Sequence-specific assignments in the 1H NMR spectrum of the human inflammatory protein C5a. |journal=Biochemistry |volume=27 |issue= 10 |pages= 3568–80 |year= 1988 |pmid= 3408713 |doi=10.1021/bi00410a007 }}

*{{cite journal | author=Stewart JL, Kolb WP, Sodetz JM |title=Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement. |journal=J. Immunol. |volume=139 |issue= 6 |pages= 1960–4 |year= 1987 |pmid= 3624872 |doi= }}

*{{cite journal | author=Buhl AM, Osawa S, Johnson GL |title=Mitogen-activated protein kinase activation requires two signal inputs from the human anaphylatoxin C5a receptor. |journal=J. Biol. Chem. |volume=270 |issue= 34 |pages= 19828–32 |year= 1995 |pmid= 7649993 |doi=10.1074/jbc.270.34.19828 }}

*{{cite journal | author=Babkina IN, Seregin SV, Daniliuk NK, ''et al.'' |title=[Chemico-enzymatic synthesis, cloning and expression of a gene for an analog of human anaphylatoxin C5a] |journal=Bioorg. Khim. |volume=21 |issue= 5 |pages= 359–64 |year= 1995 |pmid= 7661861 |doi= }}

*{{cite journal | author=Wang X, Fleischer DT, Whitehead WT, ''et al.'' |title=Inherited human complement C5 deficiency. Nonsense mutations in exons 1 (Gln1 to Stop) and 36 (Arg1458 to Stop) and compound heterozygosity in three African-American families. |journal=J. Immunol. |volume=154 |issue= 10 |pages= 5464–71 |year= 1995 |pmid= 7730648 |doi= }}

Line 32:

*{{cite journal | author=Arribas J, Arizti P, Castaño JG |title=Antibodies against the C2 COOH-terminal region discriminate the active and latent forms of the multicatalytic proteinase complex. |journal=J. Biol. Chem. |volume=269 |issue= 17 |pages= 12858–64 |year= 1994 |pmid= 8175701 |doi= }}

*{{cite journal | author=Süsal C, Kirschfink M, Kröpelin M, ''et al.'' |title=Identification of complement activation sites in human immunodeficiency virus type-1 glycoprotein gp120. |journal=Blood |volume=87 |issue= 6 |pages= 2329–36 |year= 1996 |pmid= 8630395 |doi= }}

*{{cite journal | author=Ames RS, Li Y, Sarau HM, ''et al.'' |title=Molecular cloning and characterization of the human anaphylatoxin C3a receptor. |journal=J. Biol. Chem. |volume=271 |issue= 34 |pages= 20231–4 |year= 1996 |pmid= 8702752 |doi=10.1074/jbc.271.34.20231 }}

}}

*{{cite journal | author=Fredslund F, Laursen NS, Roversi P ''et al.'' | title=Structure of and influence of a tick complement inhibitor on human complement component 5. | journal=Nat Immunol. |volume= 9 |issue= 7 |pages= 753–60 |year= 2008 |pmid= 18536718 | doi=10.1038/ni.1625 }}

Nat Immunol. |volume= 9 |issue= 7 |pages= 753-60 |year= 2008 |pmid= 18536718 }}

{{refend}}